Globus Medical (NYSE:GMED) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $112.00 price target on the stock.
Here's What Lifted Globus Medical (GMED) in Q4 [Yahoo! Finance]
Globus Medical (NYSE:GMED) was upgraded by analysts at TD Cowen to a "strong-buy" rating.
Globus Medical (NYSE:GMED) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]